Abstract
BackgroundThe wider application of T cells targeting viral tumor-antigens via their native receptors is hampered by the failure to expand potent tumor-specific T cells from patients. Here, we examine reasons...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have